PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-05-06

Date Title Company
06-May-2025 Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ) ACCESS Newswire
06-May-2025 aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region aap Implantate AG
06-May-2025 Clarity Clinic Expands PHP/IOP Mental Health Services to Arlington Heights, Bringing Specialized Care to the Northwest Suburbs ACCESS Newswire
06-May-2025 Utah Medical Products, Inc. Announces Quarterly Dividend ACCESS Newswire
06-May-2025 Infinx Acquires i3 Verticals' Healthcare Revenue Cycle Management Business ACCESS Newswire
06-May-2025 Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform ACCESS Newswire
06-May-2025 Glidewell Launches Fusion With BruxZir(TM) Zirconia ACCESS Newswire
06-May-2025 PharmaNest to Present Five Digital Pathology and AI Communications at EASL 2025, Showcasing Advances in Fibrosis and Inflammation Research ACCESS Newswire
06-May-2025 Nick Health Launches First Global Digital Cancer Care Platform Offering 24/7 Access to World-Class Oncologists ACCESS Newswire
06-May-2025 Clean Biologics appoints Laurent Claisse as CEO to accelerate US and global market expansion  Andrew Lloyd Associates
06-May-2025 Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market ACCESS Newswire
06-May-2025 Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback ACCESS Newswire
06-May-2025 Curiteva & Promimic - Bonded by Innovation ACCESS Newswire
06-May-2025 Nerva Completes Mahana Therapeutics Acquisition to Expand Access to Digital Therapies for IBS ACCESS Newswire
06-May-2025 CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company ACCESS Newswire
06-May-2025 MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity ACCESS Newswire
06-May-2025 Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization ACCESS Newswire
06-May-2025 Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D ACCESS Newswire
06-May-2025 Why Dr. Shervin Naderi is America's Top Choice for Rhinoplasty ACCESS Newswire
06-May-2025 SafeHeal(R) Closes Oversubscribed €35 Million Series C Equity Financing ACCESS Newswire